Visit https://www.peervoice.com/GSX860 to view the entire programme with slides. After completing “Advanced Basal Cell Carcinoma: An Exploration of Clinical Challenges and What the Future Could Hold”, participants will be able to: Recognise the challenges and limitations of current systemic treatment strategies for advanced basal cell carcinoma (aBCC) and how these impact patient outcomes; Describe the potential therapeutic targets related to aBCC and the emerging clinical data for these novel therapies as second-line treatment; Translate the evidence for emerging therapeutic strategies; Propose a treatment paradigm for patients with aBCC who have progressed on or are intolerant to prior Hedgehog pathway inhibitor therapy.